Chapter 39: CNS Stimulants and Attention-Deficit/Hyperactivity Disorder

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

If a child is hyperactive,

intensely impulsive, and quite literally bouncing off the walls of your clinic, why on earth is the very first line of medical defense to give them a powerful central nervous system stimulant?

I mean, isn't that basically just throwing gasoline on a fire?

You would certainly think so, right?

It is one of the absolute greatest clinical paradoxes in medicine.

Yeah.

But that assumption,

well, that's exactly why we need to completely rebuild our understanding of how stimulation actually works in the human brain, especially when you are the nurse responsible for safely administering these medications.

Right.

Which brings us to why we're here.

Welcome to the Deep Dive.

Today, we are bringing you a custom edition from our Last Minute Lecture series.

And this is tailored specifically for you, the nursing student who is probably staring down a massive pharmacology exam right now.

We've all been there.

Oh, absolutely.

Yeah.

So we are pulling directly from Lynn's Pharmacology for Nursing Care.

We're doing a deep dive into chapter 39, which is central nervous system stimulants and ADHD.

And our mission here isn't just to help you memorize a dry list of side effects.

We are really going to explore how we manipulate the brain's baseline of stimulation.

Exactly.

We want to know why these chemicals rewrite the body's operating system, and most importantly, how you actually apply that knowledge on the floor.

So to start manipulating that baseline, we kind of have to define what a CNS stimulant actually is.

Right.

Let's get the textbook definition out of the way.

Yeah.

So at their core, these drugs increase the activity of central nervous system neurons,

and they achieve this primarily by enhancing neuronal excitation,

though a select few do act by suppressing neuronal inhibition.

Okay, let's clear up a major misconception right off the bat then, because I see students get tripped up on this all the time.

If these drugs excite the brain, it's super tempting to think they're basically just fast acting antidepressants.

Oh, yeah.

That's a huge trap.

Right.

But they are entirely different beasts.

Antidepressants, well, they act selectively.

They target specific neurotransmitter pathways to elevate a patient's mood without significantly altering other CNS functions.

Precisely.

And stimulants, on the other hand, are definitely not selective.

I mean, they cannot elevate a patient's mood without producing a generalized whole body excitation.

So you get the whole packet.

Exactly.

You can't just isolate the mood boost.

You get the heightened alertness, the cardiovascular strain, the appetite suppression.

I mean, all of it at once.

Wow.

And that generalized blast to the system is exactly why their role in treating actual clinical depression is incredibly minor.

Okay.

So to really grasp the raw power of that generalized excitation, we have to examine the heavy hitters first, right?

Which means the amphetamines.

The big ones.

Yeah.

This family includes amphetamine, dextroamphetamine, methamphetamine, and Lisdex amphetamine.

And I find it really helps to visualize their chemical structure like a pair of gloves.

Oh, the glove analogy is perfect for this.

Right.

Because you have a right -handed glove and a left -handed glove.

In chemistry,

molecules that are exact mirror images on each other are called enantiomers.

And the structural difference between those mirror images dictates everything about how they behave in the body.

Exactly.

So the dextroamphetamine that's the right -handed glove,

it is highly selective for the central nervous system.

Meaning it primarily acts right on the brain.

Right.

And it causes way fewer peripheral side effects in the rest of the body.

Then you have the levomphetamine, which is the left -handed glove.

That one produces a lot more of those systemic cardiovascular side effects.

And this is key for the exam when your textbook refers to regular quote unquote amphetamine.

It is actually talking about a 50 -50 racemic mixture of both the left and right -handed versions.

50 -50 split.

Right.

Right.

Now, what is truly fascinating for clinical practice is how drug developers actually manipulate that specific chemistry to solve really severe clinical problems.

Like addiction and abuse.

Right.

Yes.

Which brings us to Lisdex amphetamine.

Most people know it better by the brand name Vyvanse.

It is prescribed heavily, but it's still a schedule two controlled substance.

Right.

The literature refers to it as having a lower potential for abuse.

But how does that actually work physiologically?

I mean, it's not like the drug simply knows it shouldn't be abused.

No, of course not.

It's essentially this brilliant chemical hack.

Lisdex amphetamine is what we call a pro -drug.

Okay.

Unpack that for us.

So the active component, dextroamphetamine,

is covalently linked to lysine, which is an amino acid.

In that combined state, the drug is completely inert.

It does nothing.

Oh, wow.

Yeah.

So if a user tries to crush it up and snort it, or maybe dissolve and inject it to get a rapid high, it does absolutely nothing in the brain.

Because the active drug is still locked inside that amino acid shell.

It hasn't been activated yet.

Exactly.

It absolutely must be swallowed.

Once it reaches the gastrointestinal tract,

enzymes in the intestine and the liver go to work.

They break it down.

Right.

They hydrolyze the molecule.

They cleave off that lysine, and that yields the free active dextroamphetamine.

That's incredibly smart.

It really is.

By designing it this way, you force the patient's own digestive enzymes to act as the gatekeeper.

This controls the release rate and completely eliminates that immediate overwhelming rush that drives the whole abuse cycle.

Okay.

So now once that active amphetamine finally hits the bloodstream, we have to look at the mechanism of action.

The primary mechanism is this massive release of two major neurotransmitters,

right?

Norepinephrine and dopamine.

Yes.

But it's actually a two -pronged attack.

How so?

Well, the amphetamines cause the presynaptic nerve terminals to dump these transmitters into the synapse, but then they also partly block the reuptake pumps.

Oh, so they flood the synapse with neurotransmitters, and then they literally plug the drains.

Exactly.

Trapping the norepinephrine and dopamine right where they are most active.

And clinically, that translates to extreme wakefulness, increased initiative, and an elevated mood.

But because it's nonselective, like we said earlier, that norepinephrine release hits the cardiovascular system really hard.

It does.

It stimulates alpha -1 receptors, causing vasoconstriction, which obviously drives up blood pressure.

Right.

And then it stimulates beta -1 receptors in the heart, increasing the heart rate and atrium ventricular conduction.

And that intense systemic effect is where we see the severe adverse effects, right?

Right.

And the reality of physical dependence.

Absolutely.

The extreme mood elevation creates the psychological dependence.

But with chronic use, the body actually adapts, which leads to physical dependence.

So what happens if they stop?

Well, if you abruptly withdraw a heavily dependent patient, they won't just feel a little bit tired.

They'll crash into a profound abstinence syndrome.

Oh, wow.

We're talking severe exhaustion, clinical depression, and prolonged sleep.

And the extreme end of the spectrum is just as dangerous.

The text highlights that excessive amphetamine use produces a state of paranoid psychosis.

Yeah, visual and auditory hallucinations, paranoia, delusions, the works.

And the mechanism here is directly tied to the dopamine, right?

Because amphetamines trigger such massive dopamine release, the amphetamine -induced psychosis looks almost clinically indistinguishable from schizophrenia.

It is a terrifying presentation for the patient.

But understanding that dopamine mechanism gives you, the nurse, the exact tool needed to intervene.

How so?

Well, because the psychosis is driven by overactive dopamine receptors, you can actually reverse those symptoms by administering a dopamine receptor blocker.

Like haloperidol.

Exactly.

Okay, let's pivot to the cardiovascular risks for a second because this brings up a massive debate in pediatric nursing.

And I know students will see this in their reading.

If these drugs consistently stimulate the heart and constrict blood vessels,

common sense suggests every single child should get an electrocardiogram and ECG before starting an ADHD medication.

It seems logical, sure.

Right.

In fact, back in 2008, the American Heart Association issued a statement saying it would be reasonable to consider doing exactly that to prevent sudden cardiac death.

So why isn't a baseline ECG standard protocol for every pediatric patient today?

This is where we have to separate theoretical physiological risk from evidence -based epidemiological reality.

Okay.

The AHA issued that statement because a very small number of children actually died suddenly while taking an amphetamine mixture.

And naturally it caused widespread alarm.

Understandably.

But subsequent massive data analysis proved that sudden death in children on these medications is incredibly rare.

Like statistically negligible.

Yes.

We are talking about millions of children taking these drugs, and their sudden death rate is no greater than the background rate you would expect for a group of that size who aren't taking the drug at all.

Oh, so the data revealed that the stimulants weren't actually creating a statistically significant increase in sudden death for healthy children.

Right.

There is simply no evidence showing that routine ECGs prevent sudden death in an otherwise healthy pediatric population.

So for the nursing exam, what's the golden rule?

The rule is crystal clear.

Unless the child has a known pre -existing heart disease or a documented hereditary cardiovascular defect,

routine ECGs before starting stimulants are unnecessary and they are not recommended.

Okay, that makes sense.

Let's shift our focus to the other structural families of stimulants.

Amphetamines are just one side of the coin.

The other major prescription stimulant is methylphenidate, which most people know as whittlein or concerta.

Yes, very common.

I always like to explain methylphenidate to patients by comparing it to the amphetamines using a car analogy.

Think of methylphenidate and amphetamines as two entirely different brands of cars that have the exact same engine under the hood.

That is a highly practical way to think about it because structurally the methylphenidate molecule is entirely dissimilar from amphetamine, but pharmacologically they act the same.

They're practically identical twins.

Methylphenidate utilizes the exact same mechanism of action promoting the release and inhibiting the reuptake of norepinephrine and dopamine.

So same engine, different badge.

Exactly.

And because the mechanism is identical, it carries the same adverse effects like insomnia and reduced appetite.

And importantly,

it shares the same schedule two abuse liability.

Got it.

But what about the stimulant that most of us actually use daily?

Let's talk about caffeine.

Ah, yes.

The nurse's best friend.

Exactly.

So caffeine belongs to a chemical family called methylhexanthines.

And caffeine is fascinating because its mechanism is entirely different from the amphetamines in methylphenidate.

It doesn't trigger that massive dump of excitatory neurotransmitters.

What does it do?

Instead, it primarily works through the reversible blockade of adenosine receptors.

Adenosine, right?

Yeah.

Adenosine is an inhibitory neuromodulator.

Basically, it promotes sleep and suppresses arousal.

So by blocking those receptors, caffeine prevents adenosine from doing its job, which indirectly promotes wakefulness.

And your textbook includes this really critical person -centered care across the lifespan chart that details exactly how we Sure.

Let's start with infants.

For them, caffeine isn't a dietary consideration at all.

It's actually a critical medical intervention in the form of caffeine citrate.

Right, for apnea.

Exactly.

We administer it to premature neonates suffering from neonatal apnea.

Because their nervous systems are underdeveloped, they literally forget to breathe.

That's terrifying.

It is.

But the caffeine stimulates their respiratory center in the medulla to keep them breathing.

Wow.

Okay.

And as we move through the lifespan to pregnancy, caffeine consumption becomes a vital monitoring point for nurses.

Right.

While definitive human data on severe birth defects is lacking,

recent epidemiological studies have demonstrated a correlation between heavy caffeine consumption and a small but very real risk for low birth weight and even miscarriage.

So pregnant patients should definitely be counseled to limit their intake.

Absolutely.

And then when assessing older adults...

Caution is absolutely required there.

Older adults are occasionally prescribed stimulants to combat severe apathy or fatigue, but the cardiovascular risks we discussed earlier, they are magnified in this population.

Because of underlying conditions.

Yes.

These drugs should be avoided entirely if the patient has significant cardiac disease or glaucoma.

The nursing protocol is always to start with a very low dose and strictly monitor their heart rate, blood pressure, and weight.

Okay.

So let's consider a patient who doesn't have ADHD, but suffers from extreme clinical sleepiness that just disrupts their entire life.

This brings us to modafinil.

Right.

Modafinil.

It's a non -amphetamine stimulant approved specifically for narcolepsy, shiftwork sleep disorder, and obstructive sleep apnea.

And modafinil allows us to target that wakefulness without the severe behavioral and cardiovascular extremes of the amphetamines.

How does it manage that?

Its mechanism is somewhat unique.

It inhibits the activity of sleep -promoting neurons in the brain, primarily by blocking the reuptake of norepinephrine, though it also heavily impacts dopamine and other neurotransmitters in the hypothalamus.

But for a nursing exam, modafinil is basically a minefield of safety alerts.

There are two major issues you absolutely have to know.

First is drug interactions.

Modafinil is a strong inducer of the CYP3A4 enzyme in the liver.

Right.

I tell students to think of the CYP enzymes like the liver's built -in waste disposal system for drugs.

If modafinil induces that enzyme, it basically spins the disposal blades faster, accelerating the metabolism of other medications in the patient's system.

And the clinical consequence of that accelerated metabolism is severe, particularly for oral contraceptives.

This is a huge exam point.

Huge.

Because if a patient on birth control starts taking modafinil, the liver will metabolize the contraceptive hormones so quickly that they never actually reach therapeutic levels.

Wow.

Yeah.

So if the nurse fails to provide that education, the patient could easily experience an unintended pregnancy.

That is a massive nursing implication.

The second major red flag with modafinil is a rare but severe dermatologic adverse effect Stevens -Johnson syndrome, along with toxic epidermal necrolysis.

SJS, yes.

And SJS isn't just a simple rash.

It is a life -threatening, immune hypersensitivity reaction where the epidermis actually separates from the underlying dermis.

It is an absolute medical emergency.

The nurse must relentlessly teach the patient to report any swelling, unexplained rash, or blistering changes in their oral mucosa immediately.

Especially if it's accompanied by a fever, right?

Exactly.

If any of those signs appear, the drug must be stopped instantly.

Okay.

So we've thoroughly covered the pharmacology of these stimulants.

Now let's bring it all back to that paradox we opened the show with and apply these drugs to their primary clinical target attention deficit hyperactivity disorder.

Right.

The ADHD paradox.

To understand it, we have to look at the pathophysiology of ADHD.

What's actually happening in the brain?

Well, while the exact cause isn't definitively proven, the core neurological issue is a dysregulation of norepinephrine, dopamine, and serotonin.

Okay.

And this dysregulation is localized in multiple brain regions, but particularly in the frontal cortex and the basal ganglia.

Those are the areas responsible for executive function, regulating attention, and suppressing impulsivity.

So back to the big question.

If the patient is already hyperactive, how does stimulating them calm them down?

Well, you have to reframe what the drug is actually doing to the brain.

Stimulants do not directly suppress rowdy behavior.

They are not sedatives.

Right.

What they do is improve the signal to noise ratio in that dysregulated preformable cortex.

By increasing norepinephrine and dopamine in those specific pathways, the stimulants improve the child's raw ability to focus.

Oh, I see.

So the hyperactivity and impulsivity, well, they drop away as a secondary effect simply because the child finally has the neurotransmitter balance required to concentrate on the task in front of them.

The brain basically stops frantically searching its environment for stimulation.

That makes so much sense.

Now, because stimulants are the absolute first -line agents for ADHD, managing a patient on them requires highly specific nursing strategies.

Yes, very specific.

Table 39 .3 in the text compares the dosing of immediate release or IR formulations versus 24 -hour long -acting formulations like Concerta or Adderall XR.

And the difference is huge in practice.

Immediate release requires two or three doses a day, which creates a complete logistical nightmare during school hours.

I can imagine.

The 24 -hour formulations are administered just once in the morning, but beyond just convenience, the 24 -hour meds provide a massive psychosocial benefit.

Right, because of the school day.

Exactly.

It completely spares the child the stigma and embarrassment of having to leave their classroom, walk all the way to the nurse's office in the middle of the day, and basically be singled out to receive their medication.

That is such an important patient -centered point.

But even with long -acting formulations, we still have to manage the side effects.

And the two biggest hurdles for pediatric patients are insomnia and growth suppression.

The big two, yeah.

So to protect the child's sleep,

the key nursing intervention is timing.

And sure, the very last dose of the day is given no later than 4 -00 p .m.

But how do we handle the growth suppression?

Well, first, it's really important to clarify that stimulants do not permanently stunt bone growth or damage the skeleton.

Well, good to know.

Yeah, the growth suppression occurs simply because the drugs are powerful appetite suppressants.

The child just isn't hungry enough to consume the calories needed for optimal growth.

They just don't want to eat.

Right.

So to combat this daily, you administer the morning dose after meals, let them eat a massive calorie -dense breakfast before the drug kicks in.

And the text also emphasizes the strategy of drug holidays, right?

Yes.

Drug holidays are crucial.

This is where the child takes a structured break from the medication on weekends or maybe summer break.

It creates this massive window for their natural appetite to return, allowing them to consume enough calories for their physical development to basically catch up.

Exactly.

When the drug is paused, a rebound increase in growth takes place, which ensures their final adult height is rarely affected.

Okay.

But what if a family flat out refuses to use stimulants?

Or what if you are treating an adult with a documented history of substance abuse?

That leads us to the non -stimulants.

Right.

The second choice drugs.

They are generally considered second choice because they aren't quite as rapidly effective, but they are absolutely crucial clinical tools.

The primary non -stimulant is atomoxetine.

Atomoxetine, yeah.

It is a highly selective norepinephrine reuptake inhibitor.

Because it doesn't trigger that massive dopamine dump, it has practically zero potential for abuse.

Which is a huge relief for a lot of patients.

Totally.

It is not a controlled substance, meaning you can easily call in refills over the phone.

But the major clinical difference is the onset of action.

Yeah.

Unlike stimulants, which work within the hour,

atomoxetine takes significant time.

How long are we talking?

The initial clinical response takes a few days, but the maximal therapeutic response takes one to three weeks to fully develop.

Oh, wow.

Up to three weeks.

Yeah.

Because the simple blockade of norepinephrine reuptake just isn't enough.

Additional really complex adaptive neurobiological processes in the brain must take place before you see the full behavioral benefit.

Okay.

So for your exam, the safety alerts for atomoxetine are heavily tested.

First, it poses a small but distinct risk for severe liver injury.

You absolutely must teach patients to report jaundice, dark urine, or unexplained abdominal tenderness.

Liver monitoring is key.

Second, it carries a black box warning.

Because it may cause suicidal thinking in children and adolescents.

You have to monitor pediatric patients intensely for agitation, irritability, or unusual behavioral changes, especially during the first few months of therapy.

And the drug interactions are potentially legal.

Let's talk about the MAOIs.

Right.

If you combine atomoxetine with a monoamine oxidase inhibitor, an MAOI, you are setting the patient up for an absolute disaster.

Why is that combination so bad?

Well, MAOIs stop the breakdown of norepinephrine.

So if you add atomoxetine, which stops the reuptake, you essentially trap all this active norepinephrine in the synapse with nowhere to go.

Oh, wow.

This causes massive systemic vasoconstriction and a deadly hypertensive crisis.

They must never be used together, and you have to wait at least three weeks after stopping an MAOI before you can even start atomoxetine.

That is a critical safety point.

Okay, the final group of non -stimulants used for ADHD are the alpha -2 adrenergic agonists, specifically guanfacine and clonidine.

Now, these drugs are famously known as blood pressure medications.

How on earth does a drug designed to lower blood pressure help a child focus?

It's all about targeting specific brain regions.

We usually think of alpha -2 receptors in the brain stem lowering blood pressure by reducing sympathetic outflow.

But in the prefrontal cortex, stimulating those alpha -2 receptors actually strengthens working memory, improves attention, and cuts out behavioral distractions.

But because they are blood pressure drugs, their side effect profile is the exact opposite of the stimulants, right?

Yes, exactly the opposite.

So instead of insomnia and weight loss, guanfacine and clonidine cause somnolence -severe sleepiness, and they cause weight gain.

So the nursing assessment must include baseline measurements of heart rate and blood pressure, checking them again with every single dose increase.

And the patient education regarding their administration is absolutely non -negotiable.

Yes.

If the patient is taking the extended -release tablets like Intuniv for guanfacine or Kapve for clonidine, they must swallow them completely intact.

Do not chew, cut, or crush them.

Right.

If they do, they will receive a massive hypotensive dose all at once.

Furthermore, you must never let the patient stop taking them abruptly.

Never.

If they quit cold turkey, the suppressed sympathetic nervous system will rebound violently, causing severe rebound hypertension.

You have to taper the dose down incredibly slowly over weeks.

So if we synthesize everything we've discussed today,

the overarching nursing implications for this entire field of pharmacology center on two things.

Rigorous baseline monitoring and proactive patient education.

Exactly.

So to wrap up this deep dive, let's solidify those end -of -chapter clinical takeaways.

Before starting any of these medications, you must assess your baselines.

Height, weight, blood pressure, and heart rate.

You must rigorously evaluate the patient for any symptomatic cardiovascular disease.

And here is a highly specific, very testable nugget.

If your patient is using the detrana transdermal methylphenidate patch, you must teach them to apply it to alternating hips each morning.

Alternating hips, right.

And tell them to leave it on for no more than nine hours.

That prevents tolerance and sleep disruption.

I want to leave you with a final thought, just to reframe how you view these medications when you're actually out on the floor.

Go for it.

Stimulants are truly unique in the medical landscape.

A pill cannot teach a child how to study, how to manage their anger, or how to interact with their peers.

No, it can't.

They do not create new positive behaviors.

All a medication does is clear the neurological static.

It reduces the biological noise so that the patient finally has the mental clarity to learn those positive behaviors themselves.

That is beautifully said.

It completely elevates your role as a nurse.

You aren't just a medication dispenser checking boxes.

You are a partner in their behavioral education, giving them the physiological foundation they need to actually succeed.

Absolutely.

Well, on behalf of the Deep Dive and our custom last -minute lecture series, we want to say a huge thank you for studying with us.

We are wishing you the absolute best of luck on your pharmacology exam.